Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Cardinal Health (CAH) Gained But Lagged the Market Today
In the latest trading session, Cardinal Health (CAH) closed at $113.28, marking a +0.1% move from the previous day.
Not All Dividend Aristocrats Are Created Alike. Here Are the 3 You Should Buy
Dividend investing has proved to be a reliable source of income for investors while allowing for long-term generational wealth accumulation.
Cardinal Health, Inc. (CAH) Baird's 2024 Global Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) Baird's 2024 Global Healthcare Conference September 10, 2024 9:05 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Eric Coldwell - Baird Eric Coldwell Good morning, everyone. My name is Eric Coldwell.
Cardinal Health (CAH) Advances But Underperforms Market: Key Facts
The latest trading day saw Cardinal Health (CAH) settling at $112.80, representing a +0.92% change from its previous close.
Cardinal Health (CAH) Morgan Stanley 22nd Annual Global Healthcare Conference Transcript
Cardinal Health, Inc. (NYSE:CAH ) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Aaron Alt - CFO Conference Call Participants Erin Wright – Morgan Stanley Erin Wright Hi, good morning, everyone. My name is Erin Wright.
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Greenville Center to Boost CAH Stock's at-Home Solution Business
Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.
Cardinal Health Q4 Earnings: FY25 Is A Short-Term Blip
Cardinal Health stock remains a buy due to strong pharmaceutical business growth and increased shareholder returns, despite short-term OptumRx and inflation challenges. Q4 and FY24 earnings exceeded expectations with revenue up 12% and gross margin up 5%, driven by pharmaceutical and medical products. DCF analysis supports a $128 price target, 17% upside, with Wall Street's average at $116; industry tailwinds bolster valuation.
Cardinal Health Soars as America's Leading Acute Care Supplier
Cardinal Health Inc. CAH is a global pharmaceutical and medical products distributor serving over 100,000 hospitals. It's also the largest distributor of medical supplies and surgical products in the United States.
Cardinal Health (CAH) to Open New Distribution Center in Ohio
Cardinal Health's (CAH) new center is set to integrate cutting-edge technology and automation, enhancing efficiency, storage capacity and quality of service.
Cardinal Health Beats Estimates, Boosts Guidance on Strong Drug Sales
Shares of Cardinal Health (CAH) gained in intraday trading Wednesday as the provider of healthcare services and products posted better-than-anticipated results and raised its outlook on strong drug sales.
